Back to search
FDAFDA · Food and drugs·Recall number D-0052-2018

Methylphenidate Hydrochloride Tablets USP, 20 mg, 100-count bottles, Rx only, Manufactured by: Watson Laboratories, Inc., Corona, CA 92880 USA, NDC 0591-5884-01.

Published November 1, 2017 · Recall initiated: October 17, 2017

Summary

FDA records drug Class III recall D-0052-2018, published November 1, 2017 and initiated October 17, 2017. Recalling firm: Teva Pharmaceuticals USA; Status: Terminated; Reported quantity: 58,292 bottles; Lot: Lot Number # 1156086M, Exp 08/18. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Dissolution Specifications: Low out of specification results for dissolution.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Teva Pharmaceuticals USA
Distributor
Nationwide in the USA and Puerto Rico
Lot
Lot Number # 1156086M, Exp 08/18
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Methylphenidate Hydrochloride Tablets USP, 20 mg, 100-count bottles, Rx only, Manufactured by: Watson Laboratories, Inc., Corona, CA 92880 USA, NDC 0591-5884-01. recalled?

Yes. FDA published recall D-0052-2018 on November 1, 2017. Reported hazard: Failed Dissolution Specifications: Low out of specification results for dissolution.

What should I do if I have this product?

Voluntary: Firm initiated · Letter